Document
IPR2019-00689, No. 1027-27 Exhibit - Nalox1027 Dowling 2008 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1027-27 Exhibit - Nalox1027 Dowling 2008 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1007-7 Exhibit - Nalox1007 US Patent No 9,192,570 Wyse (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1007-7 Exhibit - Nalox1007 US Patent No 9,192,570 Wyse (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1031-31 Exhibit - Nalox1031 Glende 2016 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1031-31 Exhibit - Nalox1031 Glende 2016 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1013-13 Exhibit - Nalox1013 Kushwaha 2011 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1013-13 Exhibit - Nalox1013 Kushwaha 2011 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1059-57 Exhibit - Nalox1059 Wermeling 2010 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1059-57 Exhibit - Nalox1059 Wermeling 2010 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1063-61 Exhibit - Nalox1063 Notice of Allowance from USP 9,468,747 FH (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1063-61 Exhibit - Nalox1063 Notice of Allowance from USP 9,468,747 FH (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1049-48 Exhibit - Nalox1049 Role of Naloxone Full Transcript (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1049-48 Exhibit - Nalox1049 Role of Naloxone Full Transcript (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1003-3 Exhibit - Nalox1003 Hochhaus Declaration 689 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1003-3 Exhibit - Nalox1003 Hochhaus Declaration 689 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1012-12 Exhibit - Nalox1012 Handbook of Pharmaceutical Excipients (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1012-12 Exhibit - Nalox1012 Handbook of Pharmaceutical Excipients (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1050-49 Exhibit - Nalox1050 Rosanske 1986 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1050-49 Exhibit - Nalox1050 Rosanske 1986 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1046-45 Exhibit - Nalox1046 Robertson 2005 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1046-45 Exhibit - Nalox1046 Robertson 2005 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1006-66 Exhibit - Nalox1006 FH 15183,441 Excerpt Dec 21, 2016 NOA (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1006-66 Exhibit - Nalox1006 FH 15183,441 Excerpt Dec 21, 2016 NOA (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1047-46 Exhibit - Nalox1047 Robertson 2009 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1047-46 Exhibit - Nalox1047 Robertson 2009 (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00689, No. 1029-29 Exhibit - Nalox1029 2003 FDA Guidance (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00689, No. 1029-29 Exhibit - Nalox1029 2003 FDA Guidance (P.T.A.B. Feb. 19, 2019)
+ More Snippets
Document
IPR2019-00690, No. 1045-44 Exhibit - Nalox1045 PDR 2010 (P.T.A.B. Feb. 19, 2019)
Cite Document
IPR2019-00690, No. 1045-44 Exhibit - Nalox1045 PDR 2010 (P.T.A.B. Feb. 19, 2019)
+ More Snippets